Participatory research in health promotion: a critical review and illustration of rationales.


Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
23 Jun 2022
Historique:
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

In health promotion research, enthusiasm for patient and public involvement (PPI) is growing. However, a lack of conceptual clarity leads to ambiguities in participatory processes and purposes, and hampers efforts to achieve and evaluate PPI in research. This study provides an overview of its underlying reasons-or rationales-so as to better understand, guide and interpret PPI in research practice. We conducted a critical review to identify typologies of rationales for PPI. We re-categorized the different types of rationales from these typologies based on their content. We illustrated the resulting categories of rationales with examples from a case study on PPI in research on Lyme disease. Five categories of rationales for PPI were identified. The democratic rationale reflects the normative right of citizens to have a voice in research. The consumerist rationale refers to the economic right of stakeholders with interests to have a say. Rooted in social justice, the transformative rationale seeks to empower marginalized groups. The substantive rationale starts from epistemic considerations and aims to improve the quality of knowledge that research generates. The instrumental rationale is of pragmatic origin and refers to improved efficiency and effectiveness of the research. Our overview of categories of rationales can be used as a frame of reference for PPI in health promotion research. Exploring, stating explicitly and reflecting on the underlying reasons for PPI may help to define realistic purposes, select matching approaches and design appropriate evaluation studies. This might also contribute to the conceptualization of PPI. Enthusiasm for patient and public involvement in health promotion research is growing. However, it often remains unclear why this involvement is being organized. This lack of clarity makes it difficult to implement such participatory research and to evaluate its added value. We searched for reasons that were given for starting patient and public involvement in research. We found five different reasons. The first is the right of all citizens to have a say in research that affects them. The second is the right of individuals to demand the best research. The third is the desire to involve and empower marginalized groups. The fourth aims to improve the quality of the knowledge generated by the research. The fifth is to achieve more effective and efficient research. Together, these reasons may help researchers get more clarity about why patients or the public should be involved in their studies. This may in turn help to define realistic purposes, design a good participatory process, and conduct appropriate evaluations. All in all, using these five reasons as a frame of reference might lead to a better understanding of what good participatory research in health promotion should look like.

Autres résumés

Type: plain-language-summary (eng)
Enthusiasm for patient and public involvement in health promotion research is growing. However, it often remains unclear why this involvement is being organized. This lack of clarity makes it difficult to implement such participatory research and to evaluate its added value. We searched for reasons that were given for starting patient and public involvement in research. We found five different reasons. The first is the right of all citizens to have a say in research that affects them. The second is the right of individuals to demand the best research. The third is the desire to involve and empower marginalized groups. The fourth aims to improve the quality of the knowledge generated by the research. The fifth is to achieve more effective and efficient research. Together, these reasons may help researchers get more clarity about why patients or the public should be involved in their studies. This may in turn help to define realistic purposes, design a good participatory process, and conduct appropriate evaluations. All in all, using these five reasons as a frame of reference might lead to a better understanding of what good participatory research in health promotion should look like.

Identifiants

pubmed: 35748283
pii: 6613570
doi: 10.1093/heapro/daac016
pmc: PMC9226656
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

ii7-ii20

Subventions

Organisme : Foundation for the Sociology of Health and Illness
Organisme : Nature of Participation as Evidence in Health Research, Policy and Practice' in 2014
Organisme : Lyme disease was funded by the Netherlands Organisation for Health Research and Development
ID : 50-50405-98-251
Organisme : Steno Diabetes Center Copenhagen
Organisme : Capital Region of Denmark
Organisme : Novo Nordisk Foundation

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

J Med Ethics. 2013 Mar;39(3):181-5
pubmed: 22267385
BMC Health Serv Res. 2014 Feb 26;14:89
pubmed: 24568690
Health Expect. 2015 Oct;18(5):661-75
pubmed: 24325553
Health Policy Plan. 2001 Sep;16(3):221-30
pubmed: 11527862
Patient. 2014;7(4):387-95
pubmed: 25034612
Soc Sci Med. 1995 Dec;41(12):1667-76
pubmed: 8746866
Health Policy. 2006 Apr;76(2):156-68
pubmed: 16006004
Aust J Prim Health. 2010;16(1):4-16
pubmed: 21133292
Res Involv Engagem. 2015 Jul 31;1:6
pubmed: 29062495
Eval Program Plann. 2013 Oct;40:42-54
pubmed: 23732440
Int J Qual Health Care. 2012 Feb;24(1):28-38
pubmed: 22109631
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Sociol Health Illn. 2017 Jan;39(1):95-111
pubmed: 27862007
Health Promot Int. 2012 Sep;27(3):416-26
pubmed: 21896575
Health Expect. 2021 Aug;24(4):1378-1390
pubmed: 34153165
Health Res Policy Syst. 2018 Feb 7;16(1):5
pubmed: 29415734
Soc Sci Med. 2018 Apr;203:1-8
pubmed: 29533876
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
PLoS One. 2014 Dec 03;9(12):e113274
pubmed: 25469705
J Health Polit Policy Law. 1993 Winter;18(4):881-904
pubmed: 8120350
Res Involv Engagem. 2018 May 24;4:16
pubmed: 29850029
Health Policy. 2002 Aug;61(2):213-36
pubmed: 12088893
J Med Ethics. 2018 Dec;44(12):801-804
pubmed: 30337451
Soc Sci Med. 2002 Jun;54(12):1825-37
pubmed: 12113438
Health Promot Int. 2011 Mar;26(1):23-36
pubmed: 20705686

Auteurs

Janneke Harting (J)

Department of Public and Occupation Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.

Kasper Kruithof (K)

Department of Ethics, Amsterdam UMC, University of Amsterdam, Law & Humanities, Amsterdam Public Health Research Institute, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.

Lotte Ruijter (L)

Department of Public and Occupation Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.

Karien Stronks (K)

Department of Public and Occupation Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH